EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The OASIS Consortium: integrating multi-omics technologies to transform chemical safety assessment

David Rouquié, Andreas Bender, Jaime Cheah iD, Christine E Crute iD, Deidre Dalmas iD, Jessica Ewald, Aaron Fullerton iD, Joshua A Harrill iD, Sabah Kadri, Nicole Kleinstreuer iD, Nynke Kramer, Jessica LaRocca und 4 weitere

Toxicological Sciences · 01.12.2025 · 208 (2) · 225-232

DOI: 10.1093/toxsci/kfaf128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicological Sciences, online erschienen am 15.09.2025. Verfasst von David Rouquié und 15 weiteren Autor:innen. Beteiligte Einrichtung: Toxicology Data Science, Bayer SAS Crop Science Division, Sophia Antipolis, 06906, France. Hauptthemen laut MEDLINE: Chemical Safety, Genomics, Toxicity Tests. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bits to Bytes Capital Call, Health and Environmental Sciences Institute, Massachusetts Life Sciences Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Next Generation Risk Assessment (NGRA) aims to improve safety testing of pharmaceuticals, agrochemicals, and industrial chemicals. NGRA employs new approach methodologies, such as novel in vitro assays coupled with exposure modeling, to minimize the use of animal models, which can fail to predict specific biological effects in humans. The strategy of the ‘Omics for Assessing Signatures for Integrated Safety (OASIS) Consortium combines multi-omics technologies (including transcriptomics, proteomics, and Cell Painting [high-content imaging]) and multiple cell model systems (ranging from simple cell cultures to complex organotypic models). By integrating these approaches with internal exposure estimates, the consortium aims to improve the translation between in vitro and in vivo test systems, ultimately enhancing the relevance of safety assessment to human biology. OASIS’s integrated approach aims to better translate the biological effects across different chemical and biological spaces, starting with the liver as a use case. By using compounds with well-characterized in vivo and in vitro nonclinical safety and toxicology data related to adverse organ-specific effects in rats and humans, OASIS aims to create novel integrated methods that improve safety assessment while reducing animal use. Ideally, these efforts will contribute to regulatory science across sectors and support the adoption of more predictive, efficient, and cost-effective toxicological models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemical SafetyGenomicsToxicity TestsAnimalsHumansAnimal Testing AlternativesMultiomicsProteomicsRisk Assessment

Stichwörter der Autor:innen

Cell PaintingNext Generation Risk Assessment (NGRA)hepatotoxicitynew approach methodologies (NAMs)omics

Autor:innen und Institutionen

  • Toxicology Data Science, Bayer SAS Crop Science Division, Sophia Antipolis, 06906, France.
  • College of Medicine and Health Sciences, Khalifa University of Science and Technology, Abu Dhabi, P.O. Box 127788, United Arab Emirates.
  • Centre for Molecular Informatics, Department of Chemistry, University of Cambridge, Cambridge, CB2 1EW, United Kingdom.
  • STAR-UBB Institute, Babeş-Bolyai University, Cluj-Napoca, 400084, Romania.
  • Center for the Development of Therapeutics, Broad Institute of MIT and Harvard, Cambridge, MA 02142, United States.
  • Health and Environmental Sciences Institute, Washington, DC 20005, United States.

ORCID-Profile: Jaime Cheah, Christine E Crute, Deidre Dalmas, Aaron Fullerton, Joshua A Harrill, Nicole Kleinstreuer, Constance A Mitchell

Förderung

  • Bits to Bytes Capital Call
  • Health and Environmental Sciences Institute
  • Massachusetts Life Sciences Center
  • OASIS Consortium

Zitieren

APA

Rouquié, D., Bender, A., Cheah, J., Crute, C. E., Dalmas, D., Ewald, J., Fullerton, A., Harrill, J. A., Kadri, S., Kleinstreuer, N., Kramer, N., LaRocca, J., Mitchell, C. A., Seal, S., Singh, S., & Carpenter, A. E. (2025). The OASIS Consortium: integrating multi-omics technologies to transform chemical safety assessment. Toxicological Sciences, 208(2), 225-232. https://doi.org/10.1093/toxsci/kfaf128

Vancouver

Rouquié D, Bender A, Cheah J, Crute CE, Dalmas D, Ewald J, et al. The OASIS Consortium: integrating multi-omics technologies to transform chemical safety assessment. Toxicological Sciences. 2025;208(2):225-232. doi:10.1093/toxsci/kfaf128

BibTeX
@article{Rouqui2025,
  author = {Rouquié, David and Bender, Andreas and Cheah, Jaime and Crute, Christine E and Dalmas, Deidre and Ewald, Jessica and Fullerton, Aaron and Harrill, Joshua A and Kadri, Sabah and Kleinstreuer, Nicole and Kramer, Nynke and LaRocca, Jessica and Mitchell, Constance A and Seal, Srijit and Singh, Shantanu and Carpenter, Anne E},
  title = {The OASIS Consortium: integrating multi-omics technologies to transform chemical safety assessment},
  journal = {Toxicological Sciences},
  year = {2025},
  volume = {208},
  number = {2},
  pages = {225--232},
  doi = {10.1093/toxsci/kfaf128}
}
Kostenlos starten →